[HTML][HTML] New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives

M Terreni, M Taccani, M Pregnolato - Molecules, 2021 - mdpi.com
The present work aims to examine the worrying problem of antibiotic resistance and the
emergence of multidrug-resistant bacterial strains, which have now become really common …

Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials

S Walesch, J Birkelbach, G Jézéquel, FPJ Haeckl… - EMBO …, 2023 - embopress.org
Antibacterial resistance is one of the greatest threats to human health. The development of
new therapeutics against bacterial pathogens has slowed drastically since the approvals of …

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE …

M Bassetti, R Echols, Y Matsunaga… - The Lancet Infectious …, 2021 - thelancet.com
Background New antibiotics are needed for the treatment of patients with life-threatening
carbapenem-resistant Gram-negative infections. We assessed the efficacy and safety of …

[HTML][HTML] Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance

S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - mdpi.com
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …

Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed

MS Butler, V Gigante, H Sati, S Paulin… - Antimicrobial agents …, 2022 - Am Soc Microbiol
There is an urgent global need for new strategies and drugs to control and treat multidrug-
resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of …

[HTML][HTML] Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter

S Dhingra, NAA Rahman, E Peile, M Rahman… - Frontiers in Public …, 2020 - frontiersin.org
Antibiotics changed medical practice by significantly decreasing the morbidity and mortality
associated with bacterial infection. However, infectious diseases remain the leading cause …

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review

M Tilahun, Y Kassa, A Gedefie… - Infection and drug …, 2021 - Taylor & Francis
Infections due to multidrug-resistant Enterobacteriaceae have become major international
public health problem due to the inadequate treatment options and the historically lagged …

The importance of sulfur-containing motifs in drug design and discovery

M Mustafa, JY Winum - Expert opinion on drug discovery, 2022 - Taylor & Francis
Introduction Sulfur-containing functional groups are privileged motifs that occur in various
pharmacologically effective substances and several natural products. Various functionalities …

Treatment options for carbapenem-resistant gram-negative bacterial infections

Y Doi - Clinical Infectious Diseases, 2019 - academic.oup.com
Antimicrobial resistance has become one of the greatest threats to public health, with rising
resistance to carbapenems being a particular concern due to the lack of effective and safe …

In vitro activity of cefiderocol against a broad range of clinically important Gram-negative bacteria

Y Yamano - Clinical Infectious Diseases, 2019 - academic.oup.com
Carbapenem-resistant gram-negative bacteria including Enterobacteriaceae as well as
nonfermenters, such as Pseudomonas aeruginosa and Acinetobacter baumannii, have …